Critical Care News and Research

RSS

Babies born to teen mothers have underdeveloped speaking skills, says study

Babies born to teen mothers have less developed speaking skills at age five than children of older mothers, a new study has found.

17 Oct 2013

NSW Health agrees to install iMDsoft's MetaVision clinical information system throughout the state

iMDsoft, a leader in clinical information systems, announced that NSW Health has signed an agreement to install MetaVision throughout the state's adult, pediatric and neonatal ICU beds.

15 Oct 2013

Patient with certain gene variation more likely to suffer cognitive decline five years after surgery

Long-term memory loss, difficulty understanding verbal or written communication or impaired ability to pay attention may still occur five years after heart surgery if a patient has a certain gene variation, according to a study presented at the ANESTHESIOLOGY 2013 annual meeting.

14 Oct 2013

Cleveland healthcare institutions receive $1M grant to develop Stroke Clinical Trials Coordinating Center

...

11 Oct 2013

Teleflex to showcase products and technologies at ANESTHESIOLOGY 2013 annual meeting

Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, is committed to helping clinicians improve patient outcomes and reduce healthcare costs. Teleflex will showcase its broad portfolio of brands, products and technologies at the ANESTHESIOLOGY 2013 annual meeting, October 12-16, in San Francisco, CA.

10 Oct 2013

Study explores impact of altitude and anemia in children with pneumonia

Pneumonia is the leading cause of death of young children around the world, and a study from an international group of researchers now finds that the risk of poor outcomes - including persistent pneumonia, secondary infections, organ failure or death - in children who contract pneumonia is four times higher in those who also have anemia and live at high altitudes (over 2,000 meters or about 6,500 feet).

9 Oct 2013

Bayer HealthCare receives FDA approval for Adempas tablets

Bayer HealthCare announced today that the United States Food and Drug Administration has approved Adempas (riociguat) tablets for: (i) the treatment of adults with persistent/recurrent chronic thromboembolic pulmonary hypertension (WHO Group 4) after surgical treatment or inoperable CTEPH to improve exercise capacity and WHO functional class; and (ii) the treatment of adults with pulmonary arterial hypertension (WHO Group 1) to improve exercise capacity, improve WHO functional class and delay clinical worsening.

9 Oct 2013

FDA approves Discovery Lab’s updated product specifications for SURFAXIN lucinactant

Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced the U.S. Food and Drug Administration (FDA) has agreed to the Company's updated product specifications for SURFAXIN® (lucinactant) Intratracheal Suspension which was approved for the prevention of respiratory distress syndrome (RDS) in premature infants at high risk for RDS.

5 Oct 2013

Pitt scientists open door to potential research into cures for Parkinson's disease

A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.

1 Oct 2013

Americans in highest socio-economic groups have 13% greater chance of surviving SAH

Americans in the highest socio-economic groups have a 13 per cent greater chance of surviving a kind of stroke known as a subarachnoid hemorrhage than those in the lowest socio-economic groups, a new study has found.

29 Sep 2013

Johns Hopkins receives $7.3M contract to reduce ventilator-associated pneumonia

The Johns Hopkins Armstrong Institute for Patient Safety and Quality has been awarded a three-year, $7.3 million contract from the Agency for Healthcare Research & Quality to bring its proven checklist for reducing ventilator-associated pneumonia — the most lethal of all hospital-acquired infections — to hospitals nationwide.

25 Sep 2013

Researchers identify molecular pathway linking ICU ventilation to brain damage

At least 30 percent of patients in intensive care units (ICUs) suffer some form of mental dysfunction as reflected in anxiety, depression, and especially delirium. In mechanically-ventilated ICU patients, the incidence of delirium is particularly high, about 80 percent, and may be due in part to damage in the hippocampus, though how ventilation is increasing the risk of damage and mental impairment has remained elusive.

25 Sep 2013

New research unveils role of ORMDL3 gene in asthma

New research from the University of Minnesota College of Veterinary Medicine has uncovered the role gene ORMDL3 plays in the disease asthma. ORMDL3, a gene recently linked to asthma susceptibility, has now been linked to the body's ability to recruit inflammatory cells during an airway allergic reaction. Study findings appear today in the journal Nature Communications.

24 Sep 2013

Falls are the leading cause of injuries in older populations

One of the top reasons for trauma admission at Vanderbilt University Medical Center may come as a surprise: falls.

23 Sep 2013

Researchers identify two accurate predictors of short-term mortality

Having the right tool to estimate surgical risk in patients at high risk for complications and death during and after surgery is crucially important, according to a study in the October issue of Anesthesiology.

19 Sep 2013

Study: Neurocognitive impairment is one of common side effects of HIV and AIDS

One of the common side effects of HIV and AIDS is neurocognitive impairments - changes in how fast a person can process information, pay attention, multi-task and remember things - yet there are no adequate tests to screen patients for these problems, according to a new study out of St. Michael's Hospital.

19 Sep 2013

Research: Steroids in spinal shots may not provide relief from lower back pain

New research from Johns Hopkins suggests that it may not be the steroids in spinal shots that provide relief from lower back pain, but the mere introduction of any of a number of fluids, such as anesthetics and saline, to the space around the spinal cord.

18 Sep 2013